Mardia Samyoung Capillary Tubes Faces Auditor Scrutiny Despite Profit

Revenue: ₹24.84 crore | Net Profit: ₹1.05 crore

Reader Takeaway: Profit reported, but auditor's critical findings on unverified assets and fund use raise serious doubts.

What just happened

Mardia Samyoung Capillary Tubes Company Ltd reported a net profit of ₹1.05 crore for the first quarter ended June 30, 2026. This marks a decline from the ₹1.15 crore profit in the preceding quarter. Revenue also saw a significant drop to ₹24.84 crore from ₹61.12 crore in the previous quarter. Earnings per share (EPS) fell to ₹0.13 from ₹0.17.

Why this matters

Despite reporting a profit, the company's financial statements have been impacted by critical observations from its statutory auditor. The auditor issued an 'Emphasis of Matter' due to several significant issues, casting doubt on the reliability of the reported figures. These include the inability to verify physical inventory, lack of documentation for substantial interest-free advances, and failure to confirm the utilization of funds raised through warrant conversion.

The backstory

During the quarter, Mardia Samyoung converted 1,17,15,000 warrants into equity shares, raising ₹15.82 crore. The company also received board approval to shift its corporate office to Ahmedabad.

What changes now

The auditor's critical observations mean that standard assurances regarding the company's financial health are lacking. Investors will need to closely watch management's response to these issues and any subsequent actions or clarifications provided.

Risks to watch

The primary risks revolve around the lack of transparency and documentation for significant financial transactions. The inability to verify assets like inventory, advances, and fund utilization directly impacts investor confidence and the perceived financial integrity of the company.

Auditor's Emphasis of Matter Details

• Inventory Verification: The auditor could not verify physical stock as of June 30, 2026, as no management representation was provided.
• Interest-Free Advances: ₹22.84 crore in interest-free advances were disbursed without supporting documentation or business rationale.
• Fund Utilization: The use of ₹15.82 crore raised via warrant conversion could not be verified due to unavailable invoices or documents.
• Balance Confirmations: Confirmations for trade receivables and payables were not obtained, and alternative audit procedures were not feasible.

Peer comparison

While specific peer financials for Q1 FY27 are not immediately available for direct comparison, the critical auditor remarks make Mardia Samyoung's disclosures stand out as requiring heightened investor scrutiny compared to typical market reporting.

Context metrics (time-bound)

• Q1 FY27 Revenue: ₹24.84 crore
• Preceding Q4 FY26 Revenue: ₹61.12 crore (Down)
• Q1 FY27 Net Profit: ₹1.05 crore
• Preceding Q4 FY26 Net Profit: ₹1.15 crore (Down)
• Interest-Free Advances: ₹22.84 crore
• Funds Raised via Warrant Conversion: ₹15.82 crore

What to track next

Investors should monitor any clarification or response from Mardia Samyoung's management regarding the auditor's observations. Future audit reports and any remediation steps taken by the company will be crucial indicators.